Adalimumab is safe and effective for noninfectious uveitis
- Posted on: Aug 10 2021
- Leave a response
In this phase 3 study, investigators report the long-term efficacy and safety of extended adalimumab treatment for noninfectious intermediate uveitis, posterior uveitis and panuveitis.
Source: AAO
Posted in: Uncategorized
